Found: 14
Select item for more details and to access through your institution.
Orphan Drug Use in Patients With Rare Diseases: A Population-Based Cohort Study.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.869842
- By:
- Publication type:
- Article
Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130209
- By:
- Publication type:
- Article
A Serum MicroRNA Signature Is Associated with the Immune Control of Chronic Hepatitis B Virus Infection.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0110782
- By:
- Publication type:
- Article
The Clinical Utility of the Saliva Proteome in Rare Diseases: A Pilot Study for Biomarker Discovery in Primary Sclerosing Cholangitis.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 2, p. 544, doi. 10.3390/jcm13020544
- By:
- Publication type:
- Article
Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 5, p. 1406, doi. 10.3390/jcm11051406
- By:
- Publication type:
- Article
Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2064, doi. 10.3390/cancers13092064
- By:
- Publication type:
- Article
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study.
- Published in:
- European Journal of Endocrinology, 2015, v. 172, n. 3, p. 269, doi. 10.1530/EJE-14-0712
- By:
- Publication type:
- Article
Predictors of serious adverse events and non‐response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2453, doi. 10.1111/liv.15386
- By:
- Publication type:
- Article
Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.
- Published in:
- Liver International, 2017, v. 37, n. 11, p. 1622, doi. 10.1111/liv.13416
- By:
- Publication type:
- Article
An Unexpected Case of Opisthorchis felineus Infection Revealed during Liver Transplantation.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
The Circulating miRNA Profile of Chronic Hepatitis D and B Patients Is Comparable but Differs from That of Individuals with HBeAg-Negative HBV Infection.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 11, p. 2257, doi. 10.3390/v15112257
- By:
- Publication type:
- Article
Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 4, p. N.PAG, doi. 10.3390/v14040701
- By:
- Publication type:
- Article
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy.
- Published in:
- Thyroid, 2015, v. 25, n. 7, p. 846, doi. 10.1089/thy.2015.0061
- By:
- Publication type:
- Article
Do the circulating Pre‐S/S quasispecies influence hepatitis B virus surface antigen levels in the HBeAg negative phase of HBV infection?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1406, doi. 10.1111/apt.15753
- By:
- Publication type:
- Article